Neurotrack is transforming the diagnosis of Alzheimer’s disease. Through a safe and non-invasive test, its technology can predict the risk of developing mild cognitive impairment and Alzheimer’s disease years before symptoms occur.
Latest funding size
Time since last funding
|about 1 month|
|Georgia Research Alliance, Johnson & Johnson, iSeed Ventures, NIH, Khosla Ventures, Social Capital, Founders Fund, AME Cloud Ventures|